02.10.2007 – 18:32 Mylan Completes Acquisition of Generics Business of Merck KGaA Pittsburgh (ots/PRNewswire) - Mylan (NYSE: MYL) announced today that it has completed its acquisition of Merck KGaA's generics business ("Merck Generics") to become one of the largest quality generics and specialty pharmaceuticals companies in the world. Mylan and Merck KGaA initially announced the signing of a definitive agreement under which Mylan would acquire Merck Generics for EUR 4.9 billion (US$6.8 billion) ... mehr
02.10.2007 – 18:25 Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations Pittsburgh (ots/PRNewswire) - Mylan Inc. (NYSE: MYL) today announced the appointment of Rajiv Malik as Executive Vice President in charge of Global Technical Operations. Mr. Malik has served in a similar capacity for Mylan since the Company acquired a controlling stake in Matrix Laboratories Limited (Matrix), where he is Chief Executive Officer, in ... mehr
02.10.2007 – 18:18 Mylan Appoints Heather Bresch as Chief Operating Officer Pittsburgh (ots/PRNewswire) - - Promoted from Head of North America Mylan Inc. (NYSE: MYL) today announced the appointment of Heather Bresch as Chief Operating Officer. Ms. Bresch served previously as Head of North America and Chief Integration Officer. As Chief Operation Officer, Ms. Bresch will be responsible for Mylan's global commercial and technical operations, strategic planning, business development and ... mehr
02.10.2007 – 17:55 Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa Pittsburgh (ots/PRNewswire) - Mylan Inc. (NYSE: MYL) today announced the appointment of Didier Barret to the position of President, EMEA (Europe, Middle East and Africa) following the completion of Mylan's acquisition of Merck's Generics Group today. At Merck Generics, M. Barret most recently served as Region Director, EMEA, reporting to the CEO. He was ... mehr
